pimobendan has been researched along with Cardiac Output, Low in 6 studies
pimobendan: produces arterial & venous dilatation in dogs; structure given in first source
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coats, A | 1 |
| Goto, Y | 1 |
| Hata, K | 1 |
| Endoh, M | 1 |
| Böhm, M | 1 |
| Morano, I | 1 |
| Pieske, B | 1 |
| Rüegg, JC | 1 |
| Wankerl, M | 1 |
| Zimmermann, R | 1 |
| Erdmann, E | 1 |
| von der Leyen, H | 1 |
| Mende, U | 1 |
| Meyer, W | 1 |
| Neumann, J | 1 |
| Nose, M | 1 |
| Schmitz, W | 1 |
| Scholz, H | 1 |
| Starbatty, J | 1 |
| Stein, B | 1 |
| Wenzlaff, H | 1 |
| Pouleur, H | 1 |
| Hanet, C | 1 |
| Schröder, E | 1 |
| Col, J | 1 |
| Van Mechelen, H | 1 |
| Etienne, J | 1 |
| Rousseau, MF | 1 |
1 review available for pimobendan and Cardiac Output, Low
| Article | Year |
|---|---|
Mechanism of action of Ca2+ sensitizers--update 2001.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Calcium; Calcium Signaling; Cardiac Output, Low; Cardiotonic Ag | 2001 |
5 other studies available for pimobendan and Cardiac Output, Low
| Article | Year |
|---|---|
Efficacy of drugs in active comparison studies.
Topics: Cardiac Output, Low; Cardiotonic Agents; Enalapril; Humans; Placebos; Pyridazines; Research Design | 1994 |
Mechanoenergetic effect of pimobendan in failing dog hearts.
Topics: Animals; Cardiac Output, Low; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; In Vitro | 1997 |
Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Calcium; Cardiac Output, Low; Contractile Proteins; Dose-Respon | 1991 |
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Benzimidazoles; Calci | 1991 |
Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
Topics: Animals; Cardiac Output, Low; Cardiotonic Agents; Dogs; Heart Failure; Heart Ventricles; Hemodynamic | 1989 |